Kathleen (Taffy) Kingscott

Kathleen Kingscott is Vice President, Strategic Partnerships for IBM Research.  She is responsible for developing collaborative research partnerships between IBM, industry, academia and government. Ms. Kingscott is a member of the National Academy of Sciences Innovation Policy Forum and is IBM’s alternate member of the Semiconductor Industry Association Board of Directors.  She chairs the CTO Work Group of the SIA. She is a member of the Board of Managers of the American Institute of Physics Publishing and is chair of the Compensation Committee for the AIPP Board.

Previously, Kathleen held the IBM Industry Chair at the Industrial College of the Armed Forces, National Defense University, as the first faculty member from industry at the college. Other earlier roles include Director, Worldwide Innovation Policy for IBM with responsibility for worldwide public policy matters regarding innovation, science and technology.  She has held other leadership roles in IBM, including Congressional relations, information technology marketing and marketing management positions. Kathleen formerly served as a member of the Executive Committee of the Electronics Division of the National Defense Industrial Association. She was a member of the Secretary of Commerce’s Manufacturing Council 2015-2016. She was a founder and served as a long-time co-chair of the Task Force on American Innovation, a major coalition of companies, university and trade associations, and professional societies that supports federal investment in scientific research.

Ms. Kingscott has been with IBM 40+ years.  She holds a B.A. from Vanderbilt University.

Securing the Future of the U.S. Biopharmaceutical Industry: The Most-Favored-Nation Paradox

By Sujai Shivakumar and Anne Pritchett The Trump administration is pursuing lowering prescription drug costs primarily to end what it describes as “global freeloading” and to ensure U.S. patients pay prices comparable to those in other developed nations. The administration argues that while the United States represents less than 5 percent
Read More

Universities, Patents, and the Future of U.S. Competitiveness

By Shruti Sharma and Chris Borges Universities are among the most powerful engines of U.S. innovation, transforming federal research investments into scientific discoveries that underpin economic growth, technological leadership, and national security. Current law, via the Bayh-Dole Act, allows universities to patent inventions and license them to private companies, with royalties
Read More

How Counterfeit Drugs Threaten U.S. Health and Innovation

By Anne Pritchett According to the Department of Homeland Security, counterfeit drugs “threaten national security and public safety directly when introduced into government and critical infrastructure supply chains, and indirectly if used to generate revenue for transnational criminal organizations.” Furthermore, counterfeit drugs harm pharmaceutical innovation by eroding profitability and investor
Read More